Dopaminergic modulation of emotional conflict in Parkinson’s disease

Dopaminergic modulation of emotional conflict in Parkinson’s disease

Neuropsychiatric fluctuations in Parkinson’s disease (PD) are frequent and disabling. One way to investigate them is to assess the ability to inhibit distractive emotional information by a modified emotional Stroop (ES) task. We compared non-depressed, non-demented PD patients with healthy controls....

Full description

Bibliographic Details
Main Author:	Vanessa eFleury
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-07-01
Series:	Frontiers in Aging Neuroscience
Subjects:	Dopamine Cingulate cortex Parkinson’s disease Emotional Stroop non-motor fluctuations
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00164/full

Similar Items

On the influence of emotion on conflict processing
by: Philipp eKanske
Published: (2012-07-01)

Differential Effects of Emotional Information on Interference Task Performance across the Life Span
by: Haley M LaMonica, et al.
Published: (2010-09-01)

Confocal analysis of cholinergic and dopaminergic inputs onto pyramidal cells in the prefrontal cortex of rodents
by: Zi-Wei Zhang, et al.
Published: (2010-06-01)

Fast oscillatory activity in the anterior cingulate cortex: dopaminergic modulation and efect of perineuronal net loss
by: Pascal eSteullet, et al.
Published: (2014-08-01)

Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial
by: K. Ray Chaudhuri, et al.
Published: (2022-03-01)

Abnormal Spontaneous Neural Activity in Parkinson’s Disease With “pure” Apathy
by: Hai-Hua Sun, et al.
Published: (2020-08-01)

Dopaminergic modulation of primary motor cortex: From cellular and synaptic mechanisms underlying motor learning to cognitive symptoms in Parkinson’s disease
by: Jérémy Cousineau, et al.
Published: (2022-06-01)

Neural substrates underlying progressive micrographia in Parkinson's disease
by: Shigenori Kanno, et al.
Published: (2020-08-01)

Differences in the resolution of emotional and cognitive conflict
by: Uroz Garelli, Damian, et al.
Published: (2014-04-01)

Neural Basis of Societal Risk for Mental Illness: Focus on Ethnic Minority Position and Racial Prejudice
by: A. Meyer-Lindenberg
Published: (2022-06-01)

Cerebellar influence on motor cortex plasticity: behavioral implications for Parkinson’s disease
by: Asha eKishore, et al.
Published: (2014-05-01)

Cognitive and Motor Components of Response Speed in the Stroop Test in Parkinson's Disease Patients
by: Yi-Hsing Hsieh, et al.
Published: (2008-04-01)

Attention for speaking: domain-general control from the anterior cingulate cortex in spoken word production
by: Vitoria ePiai, et al.
Published: (2013-12-01)

Disrupted myelination network in the cingulate cortex of Parkinson's disease
by: Song Xie, et al.
Published: (2022-05-01)

Noradrenaline and Parkinson's disease
by: Claire eDelaville, et al.
Published: (2011-05-01)

Beta band modulation by dopamine D2 receptors in the primary motor cortex and pedunculopontine nucleus in a rat model of Parkinson’s disease
by: Xuenan Wang, et al.
Published: (2022-04-01)

Effect of Pillbox Organizers with Alarms on Adherence to Pharmacotherapy in Parkinson Disease Patients Taking Three and More Daily Doses of Dopaminergic Medications
by: Igor Straka, et al.
Published: (2022-01-01)

The Stroop Effect Occurs at Multiple Points Along a Cascade of Control: Evidence From Cognitive Neuroscience Approaches
by: Marie T. Banich
Published: (2019-10-01)

Emotion recognition in early Parkinson's disease patients undergoing deep brain stimulation or dopaminergic therapy: a comparison to healthy participants
by: Lindsey G. McIntosh, et al.
Published: (2015-01-01)

The emotional valence of a conflict: Implications from synesthesia
by: Amit ePerry, et al.
Published: (2013-12-01)

Neural Correlates of Impaired Cognitive Control in Individuals with Methamphetamine Dependence: An fMRI Study
by: Ani Zerekidze, et al.
Published: (2023-01-01)

LONG-TERM DOPAMINERGIC THERAPY OF PARKINSON DISEASE
by: O. S. Levin
Published: (2017-05-01)

Parkinson’s disease, dopaminergic drugs and the plant world
by: Peter Kempster, et al.
Published: (2022-09-01)

Both Motor and Non-Motor Fluctuations Matter in the Clinical Management of Patients with Parkinson’s Disease: An Exploratory Study
by: Matteo Carpi, et al.
Published: (2023-01-01)

The alteration of gray matter volume and cognitive control in adolescents with internet gaming disorder
by: Hongmei eWang, et al.
Published: (2015-03-01)

Folding of the anterior cingulate cortex partially explains inhibitory control during childhood: A longitudinal study
by: G. Borst, et al.
Published: (2014-07-01)

Dopaminergic mesocortical projections to M1: role in motor learning and motor cortex plasticity
by: Jonas Aurel Hosp, et al.
Published: (2013-10-01)

Polymorphisms of Dopamine Receptor Genes and Parkinson’s Disease: Clinical Relevance and Future Perspectives
by: Luca Magistrelli, et al.
Published: (2021-04-01)

Association between the Degree of Pre-Synaptic Dopaminergic Pathway Degeneration and Motor Unit Firing Behavior in Parkinson’s Disease Patients
by: Yuichi Nishikawa, et al.
Published: (2021-10-01)

Intraventricular dopamine infusion alleviates motor symptoms in a primate model of Parkinson's disease
by: Caroline Moreau, et al.
Published: (2020-06-01)

Zonisamide for the Treatment of Parkinson Disease: A Current Update
by: Chengqian Li, et al.
Published: (2020-12-01)

Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson’s Disease
by: Valeria Conti, et al.
Published: (2022-05-01)

Comparative Efficacy and Safety of Dopamine Agonists in Advanced Parkinson's Disease With Motor Fluctuations: A Systematic Review and Network Meta-Analysis of Double-Blind Randomized Controlled Trials
by: Xinglin Ruan, et al.
Published: (2021-10-01)

Influence of depressive symptoms on dopaminergic treatment of Parkinson’s disease
by: Alexandru eHanganu, et al.
Published: (2014-09-01)

Identification and quantitative assessment of motor complications in Parkinson’s disease using the Parkinson’s KinetiGraph™
by: Yan Qu, et al.
Published: (2023-08-01)

Modulation of early and late event-related potentials by emotion
by: Sarah J. Hart, et al.
Published: (2012-11-01)

Neuromelanin Imaging and Dopaminergic Loss in Parkinson’s Disease
by: Ioannis Ugo Isaias, et al.
Published: (2016-08-01)

Adjuvant therapies for Parkinson’s disease: critical evaluation of safinamide
by: Stocchi F, et al.
Published: (2016-02-01)

Trait anxiety modulates fronto-limbic processing of emotional interference in Borderline Personality Disorder
by: Jana eHoltmann, et al.
Published: (2013-03-01)

Dysregulated neuromodulation in the anterior cingulate cortex in chronic pain
by: Kevin Lançon, et al.
Published: (2023-10-01)